Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting-Reference-Cited by-同舟云学术

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting

Published:2020-03 Issue:3 Volume:4 Page:357-365
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Kozieł Monika¹²,Potpara Tatjana S.³⁴,Lip Gregory Y. H.¹²⁴⁵

Affiliation:

1. Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital Liverpool UK

2. Division of Medical Sciences in Zabrze Department of Cardiology Congenital Heart Diseases and Electrotherapy Medical University of Silesia Katowice Poland

3. Cardiology Clinic Clinical Center of Serbia Belgrade Serbia

4. School of Medicine Belgrade University Belgrade Serbia

5. Aalborg Thrombosis Research Unit Department of Clinical Medicine Aalborg University Aalborg Denmark

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12319

Reference67 articles.

1. Stroke prevention in atrial fibrillation: Past, present and future

2. Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited

3. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

4. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review

5. Incidence and Severity of Coronary Artery Disease in Patients with Atrial Fibrillation Undergoing First-Time Coronary Angiography

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications;Biochemical Journal;2022-02-23

2. Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain;PLOS ONE;2021-11-12

3. Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis;Expert Review of Cardiovascular Therapy;2020-08-18